Vatorsecurities.se använder sig av cookies för att ge dig som besökare en så bra upplevelse som möjligt.

News

Vator Securities advises Ascelia Pharma on SEK 200 million IPO

6 March 2019

Vator Securities acted as Sole Global Coordinator and Bookrunner in the oversubscribed Ascelia Pharma IPO offer. The new share issue (the “Offering”) will provide Ascelia Pharma with approximately SEK 200 million before deductions for expenses related to the Offering.

Read More